Burney CO Gilead Sciences, Inc. Transaction History

Burney CO

$2.37 Billion
Q2 2024

A detailed history of Burney CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Burney CO holds 8,247 shares of GILD stock, worth $692,335. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,247

Previous 33,097 75.08%

Holding current value

$692,335

Previous $2.42 Million 76.69%

% of portfolio

0.02%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$63.15 - $72.88 $1.57 Million - $1.81 Million	-24,850 Reduced 75.08%	8,247 $565,000
Q1 2024 May 22, 2024	SELL	$71.58 - $87.29 $12,240 - $14,926	-171 Reduced 0.51%	33,097 $2.42 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $139,066 - $157,704	1,898 Added 6.05%	33,268 $2.7 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $2,735 - $2,984	37 Added 0.12%	31,370 $2.35 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $6,232 - $7,109	82 Added 0.26%	31,333 $2.41 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $222,962 - $254,022	-2,884 Reduced 8.45%	31,251 $2.59 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $416,110 - $597,391	-6,677 Reduced 16.36%	34,135 $2.93 Million
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $2.38 Million - $2.72 Million	-39,950 Reduced 49.47%	40,812 $2.52 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $41,038 - $46,222	711 Added 0.89%	80,762 $4.99 Million
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $84,794 - $106,257	-1,464 Reduced 1.8%	80,051 $4.76 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $414,777 - $470,780	6,393 Added 8.51%	81,515 $5.92 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $42,238 - $45,570	-624 Reduced 0.82%	75,122 $5.25 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $58,900 - $64,356	-928 Reduced 1.21%	75,746 $5.22 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $55,080 - $62,846	918 Added 1.21%	76,674 $4.96 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $731,011 - $832,953	-12,904 Reduced 14.55%	75,756 $4.41 Million
Q3 2020 Dec 14, 2020	SELL	$62.1 - $78.08 $96,751 - $121,648	-1,558 Reduced 1.73%	88,660 $5.6 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $570,111 - $662,004	7,881 Added 9.57%	90,218 $6.94 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $197,159 - $252,532	3,148 Added 3.98%	82,337 $6.16 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $111,532 - $122,681	-1,810 Reduced 2.23%	79,189 $5.15 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.27 Million - $1.4 Million	20,297 Added 33.44%	80,999 $5.13 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $618,019 - $693,036	9,989 Added 19.7%	60,702 $4.1 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $394,314 - $441,735	6,306 Added 14.2%	50,713 $3.3 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $665 - $869	-11 Reduced 0.02%	44,407 $2.78 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $776,880 - $860,149	-10,899 Reduced 19.7%	44,418 $3.43 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $427,559 - $498,731	6,590 Added 13.52%	55,317 $3.92 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $305,199 - $372,072	-4,190 Reduced 7.92%	48,727 $3.67 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $519,537 - $609,863	7,302 Added 16.01%	52,917 $3.79 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $328,172 - $388,973	4,551 Added 11.08%	45,615 $3.69 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $2.96 Million - $3.51 Million	41,064	41,064 $2.91 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account